Show simple item record

dc.contributor.authorMartellucci, Cecilia Acuti
dc.contributor.authorSah, Ranjit
dc.contributor.authorRabaan, Ali A.
dc.contributor.authorDhama, Kuldeep
dc.contributor.authorCasalone, Cristina
dc.contributor.authorArteaga-Livias, Kovy
dc.contributor.authorSawano, Toyoaki
dc.contributor.authorOzaki, Akihiko
dc.contributor.authorBhandari, Divya
dc.contributor.authorHiguchi, Asaka
dc.contributor.authorKotera, Yasuhiro
dc.contributor.authorFathah, Zareena
dc.contributor.authorRoy, Namrata
dc.contributor.authorUr Rahman, Mohammed Ateeq
dc.contributor.authorTanimoto, Tetsuya
dc.contributor.authorRodriguez-Morales, Alfonso J.
dc.identifier.citationMartellucci, C.A., Sah, R., Rabaan, A., Dhama, K., Casalone, C., Arteaga-Livias, K., Sawano, T., Ozaki, A., Bhandari, D., Higuchi, A., Kotera, Y., Fathah, Z., Roy, N., Ateeq, M., Rahman, U., Tanimoto, T. & Rodriguez-Morales, A. (2020). 'Changes in the spatial distribution of COVID-19 incidence in italy using gis-based maps'. Annals of Clinical Microbiology and Antimicrobials, pp. 1-4.en_US
dc.description.abstractMassive spreading of the pandemic Coronavirus Disease 2019 (COVID-19) in different continents [1, 2], have been observed. Analyses mostly focused on the number of cases per country and administrative levels, multiple times without considering the relevance of the incidence rates. These help to see the concentration of disease among the population in terms of cases per 100,000 inhabitants. Even more using geographical information systems (GIS)-based maps stakeholder may rapidly analyze changes in the epidemiological situation [3, 4]. Although the epidemic of COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in Italy on January 31, 2020, no reports on the use of GIS-based maps have been published to analyze the distinct differences in incidence rates across its regions and provinces during the last months. For these reasons, we have developed epidemiological maps of incidence rates using official populations, by regions and provinces, for COVID-19 in Italy using GIS.en_US
dc.publisherSpringer Science and Business Media LLCen_US
dc.subjectMicrobiology (medical)en_US
dc.subjectInfectious Diseasesen_US
dc.subjectGeneral Medicineen_US
dc.titleChanges in the spatial distribution of COVID-19 incidence in Italy using GIS-based mapsen_US
dc.contributor.departmentUniversity of the Marche Region, Ancona, Italyen_US
dc.contributor.departmentThe University of Tokyo, Bunkyo-ku, Tokyo, Japanen_US
dc.contributor.departmentTribhuvan University Teaching Hospital, Institute of Medicine, Kathmandu, Nepalen_US
dc.contributor.departmentJohns Hopkins Aramco Healthcare, Dhahran, Saudi Arabiaen_US
dc.contributor.departmentICAR-Indian Veterinary Research Institute, Izatnagar, Bareilly, Uttar Pradesh, 243 122, Indiaen_US
dc.contributor.departmentIstituto Zooprofilattico Sperimentale del Piemonte, Liguria e Valle d’Aosta (IZSPLV), Turin, Italyen_US
dc.contributor.departmentUniversidad Nacional Hermilio Valdizán, Huánuco, Peruen_US
dc.contributor.departmentUniversidad Cientifica del Sur, Calle Cantuarias 398, Miraflores, 15074, Lima, Peruen_US
dc.contributor.departmentSendai City Medical Center, Sendai, Miyagi, Japanen_US
dc.contributor.departmentFukushima Medical University School of Medicine, Fukushima, Japanen_US
dc.contributor.departmentJyoban Hospital of Tokiwa Foundation, Iwaki, Fukushima, Japan Medical Governance Research Institute, Minato-ku, Tokyo, Japanen_US
dc.contributor.departmentUniversity of Derbyen_US
dc.identifier.journalAnn Clin Microbiol Antimicroben_US
dc.source.journaltitleAnnals of Clinical Microbiology and Antimicrobials

Files in this item

ms_COVID19-Italy-v11_revised-a ...

This item appears in the following Collection(s)

Show simple item record
Except where otherwise noted, this item's license is described as